| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.093 | 0.005 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.005 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.005 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.006 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |